Apollo Hospitals Reports 34% Surge in FY26 Profit to Rs 1,942 Crore Driven by Strong Growth in Core Businesses
Apollo Hospitals, India’s leading healthcare provider, showcased strong financial results for the fourth quarter and fiscal year ending March 2026. The company reported a consolidated revenue increase of 18% year-on-year to Rs 6,605 crores for Q4, alongside a robust net profit growth of 36% to Rs 529 crores. For the full-year FY26, Apollo recorded a consolidated revenue rise of 16% to Rs 25,229 crores, with net profit rising 34% to Rs 1,942 crores. The impressive financial performance was largely attributed to growth across core sectors, including Healthcare Services, Diagnostics, Retail Health, and Digital Pharmacy, underscoring effective management strategies and market penetration.
Prathap C Reddy, Chairman of Apollo Hospitals, highlighted the company’s commitment to addressing the long-term healthcare needs of India, particularly in Tier 2 and Tier 3 markets. The ongoing expansion strategy includes new facility launches and significant progress on expansion projects in key cities. The company aims to enhance its healthcare services by adding 1,500 operating beds within the next 12-18 months, aiming to reach a total of 10,000 beds. Despite the ongoing regional conflicts affecting global dynamics, Apollo has not reported any notable decline in foreign patient inflows, indicating resilience in its operational strategy.
Additionally, the company is advancing its strategic initiatives, including a proposed demerger of its pharmacy and digital health divisions. This move is projected to sharpen focus on each sector, enabling accelerated growth and enhanced shareholder value, with a potential listing anticipated by Q4 FY27. The recommendation of a final dividend of Rs 10 per equity share for FY26 further reflects the company’s strong operational performance and commitment to shareholder returns. Overall, Apollo Hospitals continues to demonstrate robust growth potential, bolstered by strategic expansions and a clear focus on high-quality healthcare delivery across underserved regions.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova team.)